The US health authorities have the final green light for Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11. A few days after being approved by the Food and Drug Administration (FDA), the vaccine has now been recommended by the Centers for Disease Control and Prevention (CDC), the last step needed to launch this new phase of the vaccination campaign expected by many parents. .
The director of the CDC, Rochelle Walensky, noted that during the recent wave of the delta variant, the numbers of pediatric hospitalizations in US hospitals have skyrocketed. According to the data released, since the beginning of the pandemic, there have been 1.9 million cases of Covid-19 among children between the ages of 5 and 11, 8,300 hospitalizations and 94 deaths. In addition, 2,316 children in this age group suffered from multisystem inflammatory syndrome, which involves inflammation of several organs and is a complication of Covid-19.
The Pfizer / BioNTech vaccine for children aged 5 to 11 – which will be 10 milligrams, one third of the adult serum – will not be administered in large immunization centers, but in pediatric clinics and pharmacies. The government ensured sufficient doses of the serum for the 28 million children of this age group. The vaccination will be “fully operational” next week.
For Biden it is a “turning point”
The president of the United States Joe Biden called “a turning point” in the fight against the Covid-19 pandemic, the green light of the CDC (Centers for Disease Control and Prevention) to vaccinate children aged 5 to 11 years. “This will allow parents to end months of worry for their children, and it will reduce the rate at which children transmit the virus to others, “he said in a statement.” Today we have reached a turning point in our battle against Covid-19. ”